This study provides a mapping of EGFR mutation frequencies among BC’s health authorities, and it may subsequently aid to allot physician education and patient resources accordingly to maximize the quality of provincial NSCLC care. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.